Association of lifestyle factors and inflammation with sarcopenic obesity: data from the PREDIMED‐Plus trial
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Sarcopenia is a progressive age‐related skeletal muscle disorder associated with increased likelihood of adverse outcomes. Muscle wasting is often accompanied by an increase in body fat, leading to ‘sarcopenic obesity’. The aim of the present study was to analyse the association of lifestyle variables such as diet, dietary components, physical activity (PA), body composition, and inflammatory markers, with the risk of sarcopenic obesity. Methods: A cross‐sectional analysis based on baseline data from the PREDIMED‐Plus study was performed. A total of 1535 participants (48% women) with overweight/obesity (body mass index: 32.5 ± 3.3 kg/m 2; age: 65.2 ± 4.9 years old) and metabolic syndrome were categorized according to sex‐specific tertiles (T) of the sarcopenic index (SI) as assessed by dual‐energy X‐ray absorptiometry scanning. Anthropometrical measurements, biochemical markers, dietary intake, and PA information were collected. Linear regression analyses were carried out to evaluate the association between variables. Results: Subjects in the first SI tertile were older, less physically active, showed higher frequency of abdominal obesity and diabetes, and consumed higher saturated fat and less vitamin C than subjects from the other two tertiles (all P < 0.05). Multiple adjusted linear regression models evidenced significant positive associations across tertiles of SI with adherence to the Mediterranean dietary score (P‐trend < 0.05), PA (P‐trend < 0.0001), and the 30 s chair stand test (P‐trend < 0.0001), whereas significant negative associations were found with an inadequate vitamin C consumption (P‐trend < 0.05), visceral fat and leucocyte count (all P‐trend < 0.0001), and some white cell subtypes (neutrophils and monocytes), neutrophil‐to‐lymphocyte ratio, and platelet count (all P‐trend < 0.05). When models were additionally adjusted by potential mediators (inflammatory markers, diabetes, and waist circumference), no relevant changes were observed, only dietary variables lost significance. Conclusions: Diet and PA are important regulatory mediators of systemic inflammation, which is directly involved in the sarcopenic process. A healthy dietary pattern combined with exercise is a promising strategy to limit age‐related sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317 · cited 2×
“As described previously,31 time spent in PA (min/day) was further obtained by assigning to each activity their corresponding intensity according to the compendium of PA.32,33 Time spent in total PA was computed as the sum of the time from all PA intensities.”
MethodAdherence to a Mediterranean diet and survival in a Greek population
Trichopoulou, A., Costacou, T., Bamia, C., & Trichopoulos, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025039 · Cited by 4,397
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586 · cited 2×
“is associated with an increase in visceral fat and a progressive loss of muscle mass driven by a low-grade chronic inflammation also referred as ‘inflammaging’.(14) The excess”
BackgroundA 30-s chair-stand test as a measure of lower body strength in community-residing older adults.
Jones, C. J., Rikli, R. E., & Beam, W. C. (1999) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1999.10608028 · Cited by 2,921
Robust causal inference using directed acyclic graphs: the R package ‘dagitty’
Textor, J., van der Zander, B., Gilthorpe, M. S., Liśkiewicz, M., & Ellison, G. T. H. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw341 · Cited by 2,295
Franceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997
Fernández-Ballart, J. D., Piñol, J. L., Zazpe, I., Corella, D., Carrasco, P., Toledo, E., Perez-Bauer, M., Martínez-González, M. Á., Salas-Salvadó, J., & Martín-Moreno, J. M. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993837 · Cited by 898 · cited 1×
“At baseline, a trained dietitian administered a validated 143-item semi-quantitative food frequency questionnaire to determine dietary factors in a face-to-face visit.(26) Participants were asked about their frequency consumption of each specific item during the preceding year.”
MethodSelf-citationKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 1×
“sity are considered as the multifactorial syndromes with various overlapping causes and feedback mechanisms supposed to be strongly interconnected and aggravate each other.(40) On the other hand, the natural process of ageing”
BackgroundDual‐Energy X‐Ray Absorptiometry for Quantification of Visceral Fat
Kaul, S., Rothney, M. P., Peters, D. M., Wacker, W. K., Davis, C. E., Shapiro, M. D., & Ergun, D. L. (2012) · Obesity · doi:10.1038/oby.2011.393 · Cited by 622
Schleicher, R. L., Carroll, M. D., Ford, E. S., & Lacher, D. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27016 · Cited by 504 · cited 1×
“Some authors suggest that micronutrient intake, specifically vitamin C, is inadequate in obese subjects and subjects with metabolic syndrome.(36,37) An inadequate intake of vitamin C contributes to small overgrowth, transcytosis of enteric bacteria, and an elevation of lipopolysaccharides, which elicits a low-grade in…”
BackgroundBatsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479
Sarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453 · cited 1×
“Sarcopenia often coexists with obesity leading to a specific condition named ‘sarcopenic obesity’.(4) Current evidences”
BackgroundMuscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Chung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.09.007 · Cited by 283 · cited 1×
“5%), which provide a good estimate of the amount of skeletal muscle mass relative to body size.(25)”
BackgroundSarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198
Levine, M. E., & Crimmins, E. M. (2012) · Obesity · doi:10.1038/oby.2012.20 · Cited by 186 · cited 1×
“tween both conditions is influenced by an overproduction of inflammatory cytokines.(42,43) Hyperglycaemia, insulin resistance, and excess cytokine production have been shown to im-”
BackgroundBatsis, J. A., Mackenzie, T. A., Emeny, R. T., Lopez-Jimenez, F., & Bartels, S. J. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx002 · Cited by 116
Sarcopenic obesity, weight loss, and mortality: the english longitudinal study of ageing
Hamer, M., & O’Donovan, G. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.152488 · Cited by 110
Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly
Lim, H.-S., Park, Y.-H., Suh, K., Yoo, M. H., Park, H. K., Kim, H. J., Lee, J.-H., & Byun, D.-W. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.3.187 · Cited by 81 · cited 1×
“mediated through alterations on glucose metabolism such as hyperglycaemia and insulin resistance.(8,41) Insulin resistance often occurs with abdominal obesity, and the association be-”
BackgroundKang, S.-Y., Lim, G. E., Kim, Y. K., Kim, H. W., Lee, K., Park, T.-J., & Kim, J. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.9 · Cited by 69
Cited by
Sarcopenia and Cardiovascular Diseases
Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064071 · Cited by 645
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Inflammation and sarcopenia: A focus on circulating inflammatory cytokines
Pan, L., Xie, W., Fu, X., Lu, W., Jin, H., Lai, J., Zhang, A., Yu, Y., Li, Y., & Xiao, W. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111544 · Cited by 298
Yu, P., Hsu, C., Lee, W., Liang, C., Chou, M., Lin, M., Hsiao, F., Peng, L., & Chen, L. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12877 · Cited by 70
“Because of the potential survival benefits of the obesity paradox, the clinical impacts of sarcopenic obesity are still under debate.(12) Moreover, the operational definition of obesity in late life is controversial, and neither body mass index nor waist circumference satisfies the pathological definition of obesity.”
BackgroundSchoufour, J. D., Tieland, M., Barazzoni, R., Ben Allouch, S., Bie, J. V. D., Boirie, Y., Cruz-Jentoft, A. J., Eglseer, D., Topinková, E., Visser, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.661449 · Cited by 62
Metadata
- Authors
- Abete, I., Konieczna, J., Zulet, M. A., Galmés‐Panades, A. M., Ibero‐Baraibar, I., Babio, N., Estruch, R., Vidal, J., Toledo, E., Razquin, C., Bartolomé, R., Díaz‐Lopez, A., Fiol, M., Casas, R., Vera, J., Buil‐Cosiales, P., Pintó, X., Corbella, E., Portillo, M. P., de Paz, J. A., Martín, V., Daimiel, L., Goday, A., Rosique‐Esteban, N., Salas‐Salvadó, J., Romaguera, D., Martínez, J. A., & on behalf of PREDIMED‐PLUS Investigators
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2019-05-29
- Volume
- 10
- Issue
- 5
- Pages
- 974-984
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2947198350
- Cited by
- 81
- References
- 22
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.